One way cells can control the activities of their genes is by adding small chemical modifications to the DNA that determine which genes are turned on or off.
Newswise: Latest News
New Method Boosts the Study of Regulation of Gene Activity
July 4, 2022By
Women’s heart attacks are often missed: This gene may help explain why
June 24, 2022By
Newly identified genes may help explain why women experience different heart disease symptoms than men do, which often leads to misdiagnosing serious problems.
Latest Science News — ScienceDaily
Scientists Discover Gene Therapy Provides Neuroprotection to Prevent Glaucoma Vision Loss
July 22, 2021By
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness.
Newswise: Latest News
Prime editing enables precise gene editing without collateral damage
March 30, 2021By
The latest gene editing technology, prime editing, expands the ‘genetic toolbox’ for more precisely creating disease models and correcting genetic problems, scientists say.
Latest Science News — ScienceDaily
New ‘Split-drive’ System Puts Scientists in the (Gene) Driver Seat
March 8, 2021By
New research published in two papers by UC San Diego scientists describes novel achievements designed to make the implementation of gene drives safer and more controllable. The new split drive and home-and-rescue systems address concerns about the release of gene drives in wild populations.
Newswise: Latest News
‘Like Looking at a Miracle’: Baby Blossoms Thanks to Gene Therapy
June 10, 2019By
Arabella Smygov, 7 months, of Lynnwood, Washington was one of the first babies in the state to receive the gene therapy, Zolgensma. The U.S. Food and Drug Administration approved Zolgensma for the treatment of Spinal Muscular Atrophy in children less than 2 years of age this month.
Newswise: Latest News
Gene therapy gets FDA approval — and a $2 million price tag
May 26, 2019By
The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2.
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
January 11, 2019By
Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $ 8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.
Lonza’s virus factory shows gene therapy’s Texas-sized promise
April 11, 2018By
ZURICH (Reuters) – Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.
Gene editing technology can now fix cystic fibrosis
October 25, 2017By
Scientists at MIT and Harvard have discovered a way to use CRISPR technology to cure cystic fibrosis. With this new gene editor, they can now fix any wrong letter in the genome.
Health Articles | Mail Online
